FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Binx Health’s Chlamydia and Gonorrhea Test Gets CE Mark

May 2, 2019
A A

Binx Health has achieved a CE Mark for its chlamydia and gonorrhea multiplex test, which is used with the devicemaker’s Binx io platform.

The diagnostic provides a laboratory-quality, single-visit result in approximately thirty minutes for the sexually transmitted infections—two of the most common worldwide.

This new panel “enables a path to not just same day, but same visit testing and treatment, eliminating an immense barrier to care and cure,” says Howard Heller, the company’s chief medical officer.

View today's stories